In 2021, we performed over 300 percutaneous valve repair procedures. We are among the first hospitals in the country to adopt novel electrosurgical technologies and approaches for managing complex patients, such as:

• Basilica: coronary leaflet laceration to prevent coronary obstructio
• Transcaval TAVR to obtain percutaneous femoral access in patients with advanced peripheral arterial disease
• Tip-to-base LAMPOON and antegrade LAMPOON to perform anterior mitral valve leaflet laceration to prevent LV outflow tract obstruction

We utilize the most advanced imaging technologies to plan and guide structural interventions, such as 4D intracardiac echocardiography (ICE). Our team participates in and leads the most important clinical trials in structural disease, including:

• Intrepid TTVR EFS: Intrepid Valve for Tricuspid Regurgitation (National PI)
• TRILUMINATE: Randomized Trial of TriClip for Tricuspid Regurgitation
• CLASP 2D/2F: Randomized study of PACAL vs. MitraClip for Severe MR
• TRISCEND PIVOTAL: Randomized study of Evoque valve for Tricuspid Regurgitation
• ACURATE IDE: Randomized Trial of Acurate Valve vs. Commercial Valves for Aortic Stenosis